WuXi AppTec (TIDES)

Chinese pharmaceutical services company. Operates 20+ solid-phase peptide synthesis lines. Passed 2025 FDA inspection with zero observations. Provides peptide API and custom synthesis services with established global export logistics.

Directory assessment: WuXi AppTec (TIDES) is listed as a CDMO in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.